Please login to the form below
tramiprosate
This page shows the latest tramiprosate news and features for those working in and with pharma, biotech and healthcare.
Spinraza keeps Biogen buoyant ahead of Alzheimer’s data
Earlier this week another drug in that category, Alzheon’s tramiprosate, also reported some encouraging data in a mid-stage trial, although that involved a subgroup of patients with a genetic
Latest news
-
Alzheon says data backs potential of Alzheimer's candidate
The cognitive effect increased significantly with time, suggesting a potential disease-modifying effect of tramiprosate," they conclude. ... Tramiprosate is thought to work by inhibiting the aggregation of beta amyloid monomers into toxic oligomers.
-
Signalling change
Another once-promising anti-amyloid drug, tramiprosate, was also abandoned by Bellus Health due to inconclusive phase III study findings.
-
Halted in its tracks
Tramiprosate is a B-amyloid inhibitor that is currently in phase III development with Neurochem. ... Data presented at ICAD 2006 showed tramiprosate halts B-amyloid-induced neuronal cell death in rats.
-
Dealing with dementia
A promising late-stage candidate is Neurochem's Alzhemed (tramiprosate). This drug works by mimicking and binding to glycosaminoglycan (GAG), which promotes the formation of the amyloid-beta plaques.
More from news
Approximately 1 fully matching, plus 4 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Senior Account / Programme Manager - MedComms - Buckinghamshire
-
Highly Competitive Remuneration packages
- Freelance Medical Writer - Creative Healthcare Comms - 2 month t...
-
Excellent Day Rate
- Senior Leadership Role – Medical Communications – North West
-
Highly Competitive Salary, Bonus &Benefits
-
Account Management
-
Competitive Salary Offered
-
Principal Medical Writer
-
Varies on experience
- Freelance Account Manager - Creative Healthcare Comms - Immediat...
-
Excellent Day Rate
- Senior Content Editor - Biotechnology
-
Salary TBC
- FREELANCE Medical Writer, Senior Medical Writer, Principal Medic...
-
Highly Competitive Day Rate, Bonus &Benefits
- Pfizer helps fund biotech venture from former researchers at closed Kent facility
- CureVac expands COVID-19 vaccine trial protocol to include variant specification
- First dose of Pfizer/BioNTech vaccine reduces COVID-19 infection risk by 70%
- J&J looks ahead at potential flu therapy after approval of its COVID-19 vaccine
- New restrictions for AZ/Oxford COVID-19 vaccine despite EMA endorsement
- Lucid Group Bolster its Senior Leadership Team
- Live Webinar: Nanobiotechnology, Artificial Intelligence, and Virtual Care
- Opdivo improves survival in oesophageal cancer
- Keytruda shows significant and meaningfully improvement in kidney cancer
- Congress 2020 BC (before COVID-19)
- Shaping the Future of Medicine, Science, and Technology
- Live Webinar: Virtual Trials, Remote Care, & Cross-Border Collaboration: Ethical & Legal Challenges
PMHub
Merrill Brink International
Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....
Latest intelligence
- Virtual congresses: video thrilled the cardio tsar
- Chris Ross explores the key learnings from a year of virtual congresses...
- When Will We Be Back To Normal?
- The definitive question of 2021, whether you’re a homeschooling parent, a homebound professional, a wanderer with nowhere to go… or all three at once....
- How to tell your healthcare story.
- Healthcare research is not a simple story and the people in charge of those moments need to be careful about the story that they tell....
Quick links
Infographics
